Cargando…

A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice

Combination approaches for the treatment of metabolic diseases such as obesity and diabetes are becoming increasingly relevant. Co-administration of a glucagon-like peptide-1 receptor (GLP-1R) agonist with a cholecystokinin receptor-1 (CCKR1) agonist exert synergistic effects on weight loss in obese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hornigold, David C., Roth, Emma, Howard, Victor, Will, Sarah, Oldham, Stephanie, Coghlan, Matthew P., Blouet, Clemence, Trevaskis, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026274/ https://www.ncbi.nlm.nih.gov/pubmed/29782892 http://dx.doi.org/10.1016/j.appet.2018.05.131

Ejemplares similares

Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy
por: Roth, Emma, et al.
Publicado: (2020)

CCK‐1 and CCK‐2 receptor agonism do not stimulate GLP‐1 and neurotensin secretion in the isolated perfused rat small intestine or GLP‐1 and PYY secretion in the rat colon
por: Modvig, Ida M., et al.
Publicado: (2020)

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
por: Tanday, Neil, et al.
Publicado: (2021)

Intra-islet GLP-1, but not CCK, is necessary for β-cell function in mouse and human islets
por: de Souza, Arnaldo Henrique, et al.
Publicado: (2020)

CCK Stimulation of GLP-1 Neurons Involves α(1)-Adrenoceptor–Mediated Increase in Glutamatergic Synaptic Inputs
por: Hisadome, Kazunari, et al.
Publicado: (2011)

Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression
por: Wan, Yiping, et al.
Publicado: (2022)

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
por: Roosenburg, Susan, et al.
Publicado: (2010)

Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP‐1 but not GIP, CCK, and gastrin in plasma
por: Asmar, Ali, et al.
Publicado: (2020)

Supplementation with a fish protein hydrolysate (Micromesistius poutassou): effects on body weight, body composition, and CCK/GLP-1 secretion
por: Nobile, Vincenzo, et al.
Publicado: (2016)

Effect of Age on Blood Glucose and Plasma Insulin, Glucagon, Ghrelin, CCK, GIP, and GLP-1 Responses to Whey Protein Ingestion
por: Giezenaar, Caroline, et al.
Publicado: (2017)

CCK and GLP-1 release in response to proteinogenic amino acids using a small intestine ex vivo model in pigs
por: Müller, Maximiliano, et al.
Publicado: (2022)

Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs
por: Müller, Maximiliano, et al.
Publicado: (2023)

CCK reduces the food intake mainly through CCK1R in Siberian sturgeon (Acipenser baerii Brandt)
por: Zhang, Xin, et al.
Publicado: (2017)

Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic
por: Sukkar, Samir Giuseppe, et al.
Publicado: (2013)

Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
por: Ashurst, H Louise, et al.
Publicado: (2008)

CCK Response Deficiency in Synphilin-1 Transgenic Mice
por: Smith, Wanli W., et al.
Publicado: (2015)

The therapeutic potential of GLP‐1 receptor biased agonism
por: Jones, Ben
Publicado: (2021)

Stearic acid induces CCK and GLP-1 upregulation via GPR120/PLC-β, leading to reduced appetite in Hu sheep fed with rice straw
por: Chen, Xi, et al.
Publicado: (2022)

CCK2 receptors in chronic pain
por: LaVigne, Justin E., et al.
Publicado: (2022)

Over-expression of CCK1 Receptor Reverse Morphine Dependence
por: Hao, Lijing, et al.
Publicado: (2018)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023)

Robust anti‐obesity and metabolic effects of a dual GLP‐1/glucagon receptor peptide agonist in rodents and non‐human primates
por: Henderson, S. J., et al.
Publicado: (2016)

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
por: Marx, Nikolaus, et al.
Publicado: (2018)

A walnut-containing meal had similar effects on early satiety, CCK, and PYY, but attenuated the postprandial GLP-1 and insulin response compared to a nut-free control meal
por: Rock, Cheryl L., et al.
Publicado: (2017)

Association of CCK(1) Receptor Gene Polymorphisms and Irritable Bowel Syndrome in Korean
por: Park, Seon-Young, et al.
Publicado: (2010)

Neuronal Dystroglycan regulates postnatal development of CCK/cannabinoid receptor-1 interneurons
por: Miller, Daniel S., et al.
Publicado: (2021)

Cholecystokinin Revisited: CCK and the Hunger Trap in Anorexia Nervosa
por: Cuntz, Ulrich, et al.
Publicado: (2013)

Rediscovery of Ceruletide, a CCK Agonist, as an Analgesic Drug
por: Keppel Hesselink, Jan M
Publicado: (2020)

The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
por: Wootten, Denise, et al.
Publicado: (2016)

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
por: Chodorge, Matthieu, et al.
Publicado: (2018)

Effects of Substitution, and Adding of Carbohydrate and Fat to Whey-Protein on Energy Intake, Appetite, Gastric Emptying, Glucose, Insulin, Ghrelin, CCK and GLP-1 in Healthy Older Men—A Randomized Controlled Trial
por: Giezenaar, Caroline, et al.
Publicado: (2018)

Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011)

Vestibular CCK signaling drives motion sickness–like behavior in mice
por: Machuca-Márquez, Pablo, et al.
Publicado: (2023)

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
por: Mathiesen, David S., et al.
Publicado: (2019)

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
por: Hope, David C. D., et al.
Publicado: (2021)

The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
por: Smith, Jill P., et al.
Publicado: (2016)

Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction
por: Ma, Yihe, et al.
Publicado: (2022)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_810v5l8uvukdlqomn40khues6r